A recent study reveals a surge in the use of GLP-1 medications, such as Ozempic and Wegovy, among younger age groups.

A recent study reveals a surge in the use of GLP-1 medications, such as Ozempic and Wegovy, among younger age groups. Despite the trend, local health experts advise caution, highlighting the ...

While Americans understand the benefits of GLP-1 agonist medications, 83% of Americans are unwilling to pay more than $100 in ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

By triggering weight loss using the likes of Ozempic, people can expect various possible changes to their appearance ...

Jack Daniel's is losing ground as Americans turn to cannabis, weight-loss drugs, and Gen Z snubs liquor. Discover why whiskey ...

Last week, shares of beverage group Brown-Forman plummeted by more than 18% after the company forecast a decline in annual ...

In the UK, anxiety, panic attacks and insomnia are not listed as possible side-effects for Ozempic, Wegovy or Mounjaro.

WEIGHT loss jabs could prevent a medication taken by millions of women from working – and increase patients’ risk of cancer. The British Menopause Society said the jabs could cause ...

Nurse practitioner Shawnda Dorantes says weight-loss drugs are “helping people reclaim their health and confidence like never ...

The European Medicines Agency has indicated that Novo Nordisk's drugs, Ozempic and Wegovy, may rarely cause a serious eye ...

Popular weight loss drugs promise to slim waistlines and improve our general health, but they also come with some unpleasant ...